KeyPlants AB Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Stockholm, SWE Sweden
Total Funding:N/A
Industry:Pharma
Founded:2010
Lead Investor(s):N/A

Estimated Revenue & Financials

  • KeyPlants AB's estimated annual revenue is currently $10.9M per year.
  • KeyPlants AB's estimated revenue per employee is $201,000

Employee Data

  • KeyPlants AB has 54 Employees.
  • KeyPlants AB grew their employee count by 26% last year.
  • KeyPlants AB currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
KeyPlants AB
$10.9M5426%N/A-N/A
Pharmadule Mori...
$15.5M7713%N/A-N/A
ComplyiT AB
$20.7M10312%N/A-N/A
Karo Pharma
$38.6M19248%N/A-N/A
Missing a competitor? Contribute!?
Submit

About us The business of KeyPlants comprises services in connection with challenging projects in any location of the world - project management, design studies & engineering, construction management. We offer to lead the project towards the shortest way to project completion and start-up. Our Value Proposition: Skilled and Experienced employees and partners Committed to deliver results and exceed expectations Predictability through a well established execution model

keywords:N/A

54

Number of Employees

$10.9M

Revenue (est)

1

Current Jobs

26%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

KeyPlants AB News

12-Sep-19 - Global Plants LED Grow Light Market Demand,opportunity ...

Heliospectra AB ... To present the key Plants LED Grow Light manufacturers, production, revenue, market share, and recent development.

1-Feb-17 - Saudi CDMO's fill/finish plant to offer Big Biopharma access to ...

... firm KeyPlants to design and build a fill/finish plant for biological APIs. ... the former Pharmadule AB main fabrication workshop in Sweden ...

18-Sep-15 - Historiskt samarbete i Ryskt miljard läkemedels projekt

KEYPLANTS ERHÅLLER ORDER FÖR HISTORISKT KANADENSISK-RYSKT FARMA PROJEKT. Kanada baserade ProMetic Lifesciences har ...